Do modified live virus vaccines against bovine viral diarrhea induce fetal cross-protection against HoBi-like Pestivirus?

Vet Microbiol. 2021 Sep:260:109178. doi: 10.1016/j.vetmic.2021.109178. Epub 2021 Jul 7.

Abstract

Bovine Pestivirus heterogeneity is a major challenge for vaccines against bovine viral diarrhea (BVD). In breeding herds, fetal protection is a high priority issue. To some degree, fetal infections in vaccinated heifers have been attributed to the antigenic diversity of bovine Pestiviruses. The purpose of this study was to assess fetal protection against a divergent bovine Pestivirus (Hobi-like Pestivirus, HoBiPeV) with a commercially available modified live vaccine (MLV) claiming fetal protection against BVDV 1 and BVDV 2 up to one year after the first inoculation. Five vaccinated and four unvaccinated heifers were challenged by intranasal inoculation with the HoBiPeV Italy-1/10-1 strain between 82 and 89 days after insemination, i.e. between 4 and 6 months after vaccination. At challenge, neutralizing antibody titers to HoBiPeV in vaccinated heifers were low or even undetectable. Of the four unvaccinated heifers, one control animal aborted (fetus not available) and the remaining three gave birth to HoBiPeV positive calves. Among the heifers of the vaccinated group, one aborted the fetus in the sixth month of pregnancy, which tested Pestivirus negative, while three others gave birth to healthy, HoBiPeV negative calves; the remaining heifer delivered one HoBiPeV positive calf. The results suggest that the BVDV vaccine might be able to elicit a partial fetal protection against HobiPeV, even in absence of a strong specific antibody response.

Keywords: BVD; Cattle; Fetal protection; HoBi-like Pestivirus; MLV BVDV vaccines.

MeSH terms

  • Animals
  • Antibodies, Neutralizing
  • Bovine Virus Diarrhea-Mucosal Disease / prevention & control*
  • Bovine Virus Diarrhea-Mucosal Disease / virology
  • Cattle
  • Cross Protection
  • Diarrhea Virus 1, Bovine Viral / immunology*
  • Diarrhea Virus 2, Bovine Viral / immunology*
  • Female
  • Fetus / virology
  • Hemorrhagic Syndrome, Bovine / prevention & control*
  • Hemorrhagic Syndrome, Bovine / virology
  • Pregnancy
  • Pregnancy Complications, Infectious / prevention & control
  • Pregnancy Complications, Infectious / veterinary*
  • Pregnancy Complications, Infectious / virology
  • Vaccines, Attenuated / immunology
  • Viral Vaccines / immunology*

Substances

  • Antibodies, Neutralizing
  • Vaccines, Attenuated
  • Viral Vaccines